Postburn edema and related changes in interleukin-2, leukocytes, platelet activation, endothelin-1, and C1 esterase inhibitor

Journal of Burn Care and Rehabilitation

Volumn 18, Issue 2, 1997, Pages 99-103

  Kowal Vern, Areta ^b   Walenga, Jeanine M ^b   Sharp Pucci, Marymargaret ^b   Hoppensteadt, Debra ^b   Gamelli, Richard L ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; COMPLEMENT COMPONENT C1S INHIBITOR; ENDOTHELIN 1; INTERLEUKIN 2; THROMBOCYTE FACTOR 4; THROMBOXANE B2;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD VESSEL PERMEABILITY; BURN; CHILD; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; INFANT; LEUKOCYTOSIS; LUNG BURN; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; MULTIPLE ORGAN FAILURE; NEUTROPHIL; THROMBOCYTE ACTIVATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BURNS; CHILD; CHILD, PRESCHOOL; COMPLEMENT C1 INACTIVATOR PROTEINS; EDEMA; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFANT; INTERLEUKIN-2; LEUKOCYTES; MALE; MIDDLE AGED; PLATELET ACTIVATION;

EID: 0030937537     PISSN: 02738481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004630-199703000-00002     Document Type: Article

References (21)

1. Lindahl OA, Zdolsek J, Sjöberg F, and Ängquist K-A. Human postburn oedema measured with the impression method. Burns 1993;19:479-84.
2. Lotze MT, Matory YL, Rayner AA, et al. Clinical effects and toxicity of interleukin-2 in patients with cancer. Cancer 1986; 58:2764-72.
3. Harms BA, Pahl AC, Pohlman TH, Conhaim RL, Starling JR, Storm FK. Effects of interleukin-2 on pulmonary and systemic transvascular fluid filtration. Surgery 1989;106:339-46.
4. Welbourn R, Goldman G, Kobzik L, et al. Involvement of thromboxane and neutrophils in multiple-system organ edema with interleukin-2. Ann Surg 1990;212:728-33.
5. Ferro TJ, Johnson A, Everitt J, Malik AB. IL-2 induces pulmonary edema and vasoconstriction independent of circulating lymphocytes. J Immunol 1989;142:1916-21.
6. Klausner JM, Morel N, Paterson IS, Kobzik L, Valeri CR, Eberlein TJ, Shepro D, Hechtman HB. The rapid induction by interleukin-2 of pulmonary microvascular permeability. Ann Surg 1989;209:119-28.
7. Michie HR, Eberlein TJ, Spriggs DR, Manogue KR, Cerami A, Wilmore DW. Interleukin-2 initiates metabolic responses associated with critical illness in humans. Ann Surg 1988;208: 493-503.
8. Kowal-Vern A, Gamelli RL, Walenga JM, Hoppensteadt D, Sharp-Pucci M, Schumacher H. The effect of burn wound size on hemostasis: a correlation of the hemostatic changes to the clinical state. J Trauma 1992;33:50-7.
9. 1 esterase inhibitor in patients with vascular leak syndrome after bone marrow transplantation. Ann Hematol 1993;67:17-21.
10. Kowal-Vern A, Walenga WM, Hoppensteadt D, Sharp-Pucci M, Gamelli RL. Interleukin-2 and interteukin-6 in relation to burn wound size in the acute phase of thermal injury. J Am Coll Surg 1994;178:357-62.
11. Huribal M, Cunningham ME, D'Aiuto ML, Pleban WE, McMillen MA. Endothelin levels in patients with burns covering more than 20% body surface area. J Burn Care Rehabil 1995;16:23-6.
12. 2 increase in patients with burns. J Am Coll Surg 1995;180:318-22.
13. Patrignani P, Del Maschio A, Bazzoni G, et al. Inactivation of endothelin by polymorphonuclear leukocyte-derived lytic enzymes. Blood 1991;78:2715-20.
14. Gamelli RL, George M, Sharp-Pucci M-M, Dries DJ, Radisavljevic Z. Burn-induced nitric oxide release in humans. J Trauma 1995;39:1141-4.
15. King AJ, Brenner BM, Anderson S. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol 1989;256: F1051-8.
16. Miller W, Redfield MM, Burnett JC. Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest 1989;83: 317-20.
17. Huang Y-S, Li A(N), Yang Z-C. Role of thromboxane and prostacyclin in the pathogenesis of acute respiratory failure in burn patients combined with inhalation injury. Burns 1992; 18:452-5.
18. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American college of chest physicians/society of critical care medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
19. Carrico CJ. The elusive pathophysiology of the multiple organ failure syndrome. Ann Surg 1993;218:109-10.
20. Marshall JC, Christou NV, Meakins JL. The gastrointestinal tract: the undrained abscess of multiple organ failure. Ann Surg 1993;218:111-9.
21. Butterfield JH, Leiferman KM, Abrams J, et al. Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. Blood 1992;79:688-92.